Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Different-dose cyclosporine A for aplastic anemia
ChiCTR-TRC-13003833Phase 4Recruiting
- Sponsor
- Tianjin Medical University General Hospital
- Start
- Nov 2013
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of cyclosporine in aplastic anemia (2 arms), sponsored by Tianjin Medical University General Hospital. Primary endpoints: Fasting blood concentration of cyclosporine A, 2-hour post-dose cyclosporine A blood concentration (C2) and 16 more. Started Nov 2013; status: recruiting.
02
Drugs
cyclosporine
03
Conditions
aplastic anemia
Beyond the preview
Go deeper on ChiCTR-TRC-13003833.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-13003833.